These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 36564601)

  • 1. YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches.
    Piccolo S; Panciera T; Contessotto P; Cordenonsi M
    Nat Cancer; 2023 Jan; 4(1):9-26. PubMed ID: 36564601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP/TAZ at the Roots of Cancer.
    Zanconato F; Cordenonsi M; Piccolo S
    Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.
    Molina ER; Chim LK; Salazar MC; Mehta SM; Menegaz BA; Lamhamedi-Cherradi SE; Satish T; Mohiuddin S; McCall D; Zaske AM; Cuglievan B; Lazar AJ; Scott DW; Grande-Allen JK; Ludwig JA; Mikos AG
    Acta Biomater; 2019 Dec; 100():38-51. PubMed ID: 31542501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEPTIN10-mediated crosstalk between cytoskeletal networks controls mechanotransduction and oncogenic YAP/TAZ signaling.
    Weiler SME; Bissinger M; Rose F; von Bubnoff F; Lutz T; Ori A; Schirmacher P; Breuhahn K
    Cancer Lett; 2024 Mar; 584():216637. PubMed ID: 38242197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models.
    Du W; Du W; Wan M; Zhou X; Xu X; Zheng L
    Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Biomaterials and Model Systems to Study YAP/TAZ in Cancer.
    Villares E; Gerecht S
    ACS Biomater Sci Eng; 2024 Sep; 10(9):5550-5561. PubMed ID: 39190867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation.
    Castillo C; Grieco M; D'Amone S; Lolli MG; Ursini O; Cortese B
    Cancer Lett; 2024 Apr; 588():216792. PubMed ID: 38453044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP/TAZ as therapeutic targets in cancer.
    Zanconato F; Battilana G; Cordenonsi M; Piccolo S
    Curr Opin Pharmacol; 2016 Aug; 29():26-33. PubMed ID: 27262779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell.
    Plouffe SW; Lin KC; Moore JL; Tan FE; Ma S; Ye Z; Qiu Y; Ren B; Guan KL
    J Biol Chem; 2018 Jul; 293(28):11230-11240. PubMed ID: 29802201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers.
    Lo Sardo F; Canu V; Maugeri-Saccà M; Strano S; Blandino G
    Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188756. PubMed ID: 35777600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into recent findings and clinical application of YAP and TAZ in cancer.
    Franklin JM; Wu Z; Guan KL
    Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.
    Kegelman CD; Collins JM; Nijsure MP; Eastburn EA; Boerckel JD
    Curr Osteoporos Rep; 2020 Oct; 18(5):526-540. PubMed ID: 32712794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy.
    Reggiani F; Gobbi G; Ciarrocchi A; Ambrosetti DC; Sancisi V
    Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188341. PubMed ID: 31931113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights gained from computational modeling of YAP/TAZ signaling for cellular mechanotransduction.
    Jafarinia H; Khalilimeybodi A; Barrasa-Fano J; Fraley SI; Rangamani P; Carlier A
    NPJ Syst Biol Appl; 2024 Aug; 10(1):90. PubMed ID: 39147782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
    Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
    Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.
    Zhang Y; Wang Y; Ji H; Ding J; Wang K
    J Exp Clin Cancer Res; 2022 Jun; 41(1):202. PubMed ID: 35701841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.